Christiaan de Wilde
Amministratore Delegato presso Fujirebio Europe NV
Posizioni attive di Christiaan de Wilde
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Fujirebio Europe NV
 Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | Amministratore Delegato | 01/01/2006 | - |
Fujirebio Germany GmbH
 Fujirebio Germany GmbH Pharmaceuticals: MajorHealth Technology Part of H.U. Group Holdings, Inc., Fujirebio Germany GmbH develops and manufactures pharmaceutical products. The company is based in Hannover, Germany. The CEO of the company is Christiaan de Wilde. | Amministratore Delegato | - | - |
Storia della carriera di Christiaan de Wilde
Precedenti posizioni note di Christiaan de Wilde
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Johnson & Johnson Medical, Inc.
 Johnson & Johnson Medical, Inc. Medical SpecialtiesHealth Technology Part of Johnson & Johnson, Johnson & Johnson Medical, Inc. is a company that manufactures surgical appliances. The company is based in Arlington, TX. | Direttore Finanziario/CFO | 01/06/2000 | 01/05/2005 |
Janssen-Cilag International NV
 Janssen-Cilag International NV BiotechnologyHealth Technology Part of Johnson & Johnson, Janssen-Cilag International NV is a Belgian company that develops novel medicines and solutions. Bart Willem van Zijll Langhout has been the CEO of the company since 2009. | Direttore/Membro del Consiglio | 01/05/2005 | - |
Statistiche
Distribuzione geografica
| Belgio | 3 |
| Stati Uniti | 2 |
| Germania | 2 |
Posizioni
| Chief Executive Officer | 2 |
| Director of Finance/CFO | 1 |
| Director/Board Member | 1 |
Settori
| Health Technology | 5 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 4 |
|---|---|
Fujirebio Europe NV
Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | Health Technology |
Johnson & Johnson Medical, Inc.
Johnson & Johnson Medical, Inc. Medical SpecialtiesHealth Technology Part of Johnson & Johnson, Johnson & Johnson Medical, Inc. is a company that manufactures surgical appliances. The company is based in Arlington, TX. | Health Technology |
Janssen-Cilag International NV
Janssen-Cilag International NV BiotechnologyHealth Technology Part of Johnson & Johnson, Janssen-Cilag International NV is a Belgian company that develops novel medicines and solutions. Bart Willem van Zijll Langhout has been the CEO of the company since 2009. | Health Technology |
Fujirebio Germany GmbH
Fujirebio Germany GmbH Pharmaceuticals: MajorHealth Technology Part of H.U. Group Holdings, Inc., Fujirebio Germany GmbH develops and manufactures pharmaceutical products. The company is based in Hannover, Germany. The CEO of the company is Christiaan de Wilde. | Health Technology |
- Borsa valori
- Insiders
- Christiaan de Wilde
- Esperienza
